nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenobarbital—ABCC3—hematologic cancer	0.195	0.832	CbGaD
Phenobarbital—ABCB1—hematologic cancer	0.0395	0.168	CbGaD
Phenobarbital—CYP1B1—Procarbazine—hematologic cancer	0.0264	0.0494	CbGbCtD
Phenobarbital—ABCC1—Idarubicin—hematologic cancer	0.0142	0.0266	CbGbCtD
Phenobarbital—CYP1B1—Daunorubicin—hematologic cancer	0.0142	0.0265	CbGbCtD
Phenobarbital—ABCB11—Daunorubicin—hematologic cancer	0.0142	0.0265	CbGbCtD
Phenobarbital—CYP4A11—Cisplatin—hematologic cancer	0.0133	0.0249	CbGbCtD
Phenobarbital—CYP2C18—Ifosfamide—hematologic cancer	0.012	0.0224	CbGbCtD
Phenobarbital—CYP4A11—Dexamethasone—hematologic cancer	0.0107	0.0201	CbGbCtD
Phenobarbital—ABCC1—Daunorubicin—hematologic cancer	0.0101	0.0188	CbGbCtD
Phenobarbital—CYP1B1—Dasatinib—hematologic cancer	0.00871	0.0163	CbGbCtD
Phenobarbital—CYP1B1—Mitoxantrone—hematologic cancer	0.0086	0.0161	CbGbCtD
Phenobarbital—CYP2A6—Methoxsalen—hematologic cancer	0.00799	0.015	CbGbCtD
Phenobarbital—CHRFAM7A—ovarian follicle—hematologic cancer	0.00746	0.196	CbGeAlD
Phenobarbital—ABCC2—Daunorubicin—hematologic cancer	0.00744	0.0139	CbGbCtD
Phenobarbital—ABCC3—Vincristine—hematologic cancer	0.00685	0.0128	CbGbCtD
Phenobarbital—CYP1A2—Anagrelide—hematologic cancer	0.00683	0.0128	CbGbCtD
Phenobarbital—CYP1A1—Methoxsalen—hematologic cancer	0.00683	0.0128	CbGbCtD
Phenobarbital—CYP2B6—Thiotepa—hematologic cancer	0.00669	0.0125	CbGbCtD
Phenobarbital—CYP1A1—Bortezomib—hematologic cancer	0.00649	0.0122	CbGbCtD
Phenobarbital—ABCC3—Cisplatin—hematologic cancer	0.00639	0.012	CbGbCtD
Phenobarbital—ABCC3—Etoposide—hematologic cancer	0.00628	0.0117	CbGbCtD
Phenobarbital—CYP1A1—Daunorubicin—hematologic cancer	0.00621	0.0116	CbGbCtD
Phenobarbital—ABCC1—Mitoxantrone—hematologic cancer	0.00611	0.0114	CbGbCtD
Phenobarbital—CHRNA7—ovarian follicle—hematologic cancer	0.00602	0.158	CbGeAlD
Phenobarbital—ABCB11—Vinblastine—hematologic cancer	0.00602	0.0113	CbGbCtD
Phenobarbital—ABCB11—Vincristine—hematologic cancer	0.00592	0.0111	CbGbCtD
Phenobarbital—CYP2A6—Ifosfamide—hematologic cancer	0.00583	0.0109	CbGbCtD
Phenobarbital—CYP1A1—Thalidomide—hematologic cancer	0.00566	0.0106	CbGbCtD
Phenobarbital—ABCC1—Epirubicin—hematologic cancer	0.00495	0.00926	CbGbCtD
Phenobarbital—CYP1A1—Dacarbazine—hematologic cancer	0.00486	0.0091	CbGbCtD
Phenobarbital—ABCC1—Irinotecan—hematologic cancer	0.00481	0.009	CbGbCtD
Phenobarbital—ABCB11—Dexamethasone—hematologic cancer	0.00446	0.00835	CbGbCtD
Phenobarbital—CYP1B1—Dexamethasone—hematologic cancer	0.00446	0.00835	CbGbCtD
Phenobarbital—CYP2E1—Thalidomide—hematologic cancer	0.00437	0.00818	CbGbCtD
Phenobarbital—ABCC3—Doxorubicin—hematologic cancer	0.00428	0.00801	CbGbCtD
Phenobarbital—ABCC1—Vinblastine—hematologic cancer	0.00428	0.00801	CbGbCtD
Phenobarbital—CYP2C9—Bexarotene—hematologic cancer	0.00426	0.00798	CbGbCtD
Phenobarbital—ABCC1—Vincristine—hematologic cancer	0.00421	0.00787	CbGbCtD
Phenobarbital—ABCC3—Methotrexate—hematologic cancer	0.00415	0.00776	CbGbCtD
Phenobarbital—ABCB1—Lenalidomide—hematologic cancer	0.00414	0.00775	CbGbCtD
Phenobarbital—CYP3A7—Ifosfamide—hematologic cancer	0.00399	0.00746	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00399	0.00746	CbGbCtD
Phenobarbital—CYP2A6—Prednisolone—hematologic cancer	0.00389	0.00727	CbGbCtD
Phenobarbital—ABCC1—Etoposide—hematologic cancer	0.00385	0.00721	CbGbCtD
Phenobarbital—CYP1A1—Dasatinib—hematologic cancer	0.00382	0.00715	CbGbCtD
Phenobarbital—CYP3A7—Imatinib—hematologic cancer	0.00381	0.00712	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00381	0.00712	CbGbCtD
Phenobarbital—CYP2B6—Ifosfamide—hematologic cancer	0.00379	0.0071	CbGbCtD
Phenobarbital—CYP2E1—Dacarbazine—hematologic cancer	0.00376	0.00703	CbGbCtD
Phenobarbital—CYP2C8—Bortezomib—hematologic cancer	0.00375	0.00701	CbGbCtD
Phenobarbital—CYP3A5—Daunorubicin—hematologic cancer	0.00373	0.00698	CbGbCtD
Phenobarbital—CYP1B1—Doxorubicin—hematologic cancer	0.0037	0.00692	CbGbCtD
Phenobarbital—ABCB11—Doxorubicin—hematologic cancer	0.0037	0.00692	CbGbCtD
Phenobarbital—CYP1A2—Carmustine—hematologic cancer	0.00359	0.00671	CbGbCtD
Phenobarbital—ABCC2—Irinotecan—hematologic cancer	0.00356	0.00666	CbGbCtD
Phenobarbital—CYP2C9—Idarubicin—hematologic cancer	0.00353	0.00661	CbGbCtD
Phenobarbital—CYP3A5—Thalidomide—hematologic cancer	0.0034	0.00635	CbGbCtD
Phenobarbital—CYP2B6—Nilotinib—hematologic cancer	0.00329	0.00617	CbGbCtD
Phenobarbital—CYP3A5—Teniposide—hematologic cancer	0.00324	0.00606	CbGbCtD
Phenobarbital—ABCC2—Vinblastine—hematologic cancer	0.00317	0.00593	CbGbCtD
Phenobarbital—CYP2C19—Bortezomib—hematologic cancer	0.00314	0.00588	CbGbCtD
Phenobarbital—ABCC2—Vincristine—hematologic cancer	0.00311	0.00583	CbGbCtD
Phenobarbital—CYP1A2—Methoxsalen—hematologic cancer	0.00305	0.00571	CbGbCtD
Phenobarbital—CYP3A5—Ifosfamide—hematologic cancer	0.00299	0.00559	CbGbCtD
Phenobarbital—CYP2E1—Mitoxantrone—hematologic cancer	0.00292	0.00546	CbGbCtD
Phenobarbital—ABCC2—Cisplatin—hematologic cancer	0.0029	0.00543	CbGbCtD
Phenobarbital—CYP1A2—Bortezomib—hematologic cancer	0.0029	0.00543	CbGbCtD
Phenobarbital—CYP2C8—Ifosfamide—hematologic cancer	0.00287	0.00538	CbGbCtD
Phenobarbital—CYP3A5—Imatinib—hematologic cancer	0.00286	0.00534	CbGbCtD
Phenobarbital—ABCC2—Etoposide—hematologic cancer	0.00285	0.00534	CbGbCtD
Phenobarbital—CYP1A2—Daunorubicin—hematologic cancer	0.00277	0.00519	CbGbCtD
Phenobarbital—CYP2C19—Thalidomide—hematologic cancer	0.00274	0.00513	CbGbCtD
Phenobarbital—CYP1A2—Alitretinoin—hematologic cancer	0.00272	0.00509	CbGbCtD
Phenobarbital—ABCC1—Doxorubicin—hematologic cancer	0.00263	0.00492	CbGbCtD
Phenobarbital—CYP2C9—Bortezomib—hematologic cancer	0.00261	0.00489	CbGbCtD
Phenobarbital—CYP2C19—Teniposide—hematologic cancer	0.00261	0.00489	CbGbCtD
Phenobarbital—ABCC1—Methotrexate—hematologic cancer	0.00255	0.00476	CbGbCtD
Phenobarbital—CYP1A2—Thalidomide—hematologic cancer	0.00253	0.00473	CbGbCtD
Phenobarbital—CYP2C8—Nilotinib—hematologic cancer	0.0025	0.00467	CbGbCtD
Phenobarbital—CYP3A4—Bexarotene—hematologic cancer	0.00248	0.00464	CbGbCtD
Phenobarbital—ABCB1—Daunorubicin—hematologic cancer	0.00243	0.00454	CbGbCtD
Phenobarbital—CYP2C19—Ifosfamide—hematologic cancer	0.00241	0.00451	CbGbCtD
Phenobarbital—CYP3A7—Irinotecan—hematologic cancer	0.00238	0.00445	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00238	0.00445	CbGbCtD
Phenobarbital—ABCB1—Alitretinoin—hematologic cancer	0.00238	0.00445	CbGbCtD
Phenobarbital—ABCC2—Dexamethasone—hematologic cancer	0.00235	0.00439	CbGbCtD
Phenobarbital—CYP3A4—Busulfan—hematologic cancer	0.00231	0.00431	CbGbCtD
Phenobarbital—CYP3A4—Lomustine—hematologic cancer	0.00231	0.00431	CbGbCtD
Phenobarbital—CYP2C19—Imatinib—hematologic cancer	0.0023	0.00431	CbGbCtD
Phenobarbital—CYP3A5—Dasatinib—hematologic cancer	0.00229	0.00429	CbGbCtD
Phenobarbital—CYP2A6—Dexamethasone—hematologic cancer	0.00229	0.00429	CbGbCtD
Phenobarbital—CYP2C9—Thalidomide—hematologic cancer	0.00228	0.00426	CbGbCtD
Phenobarbital—CYP2B6—Irinotecan—hematologic cancer	0.00226	0.00424	CbGbCtD
Phenobarbital—CYP1A2—Dacarbazine—hematologic cancer	0.00217	0.00407	CbGbCtD
Phenobarbital—CYP2C9—Teniposide—hematologic cancer	0.00217	0.00407	CbGbCtD
Phenobarbital—CYP1A2—Imatinib—hematologic cancer	0.00213	0.00398	CbGbCtD
Phenobarbital—CYP3A7—Vincristine—hematologic cancer	0.00208	0.00389	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00208	0.00389	CbGbCtD
Phenobarbital—CYP3A4—Thiotepa—hematologic cancer	0.00205	0.00385	CbGbCtD
Phenobarbital—CYP2C9—Ifosfamide—hematologic cancer	0.002	0.00375	CbGbCtD
Phenobarbital—CYP1A1—Dexamethasone—hematologic cancer	0.00196	0.00366	CbGbCtD
Phenobarbital—ABCC2—Doxorubicin—hematologic cancer	0.00195	0.00364	CbGbCtD
Phenobarbital—CYP2C9—Imatinib—hematologic cancer	0.00192	0.00358	CbGbCtD
Phenobarbital—ABCC2—Methotrexate—hematologic cancer	0.00188	0.00353	CbGbCtD
Phenobarbital—ABCB1—Imatinib—hematologic cancer	0.00186	0.00348	CbGbCtD
Phenobarbital—CYP2B6—Cisplatin—hematologic cancer	0.00185	0.00345	CbGbCtD
Phenobarbital—CYP2E1—Etoposide—hematologic cancer	0.00184	0.00344	CbGbCtD
Phenobarbital—CYP3A5—Irinotecan—hematologic cancer	0.00178	0.00334	CbGbCtD
Phenobarbital—CYP2C9—Nilotinib—hematologic cancer	0.00174	0.00326	CbGbCtD
Phenobarbital—CYP1A2—Dasatinib—hematologic cancer	0.00171	0.00319	CbGbCtD
Phenobarbital—ABCB1—Nilotinib—hematologic cancer	0.00169	0.00316	CbGbCtD
Phenobarbital—ABCB1—Vinorelbine—hematologic cancer	0.00167	0.00313	CbGbCtD
Phenobarbital—CYP3A4—Methoxsalen—hematologic cancer	0.0016	0.00299	CbGbCtD
Phenobarbital—CYP3A7—Dexamethasone—hematologic cancer	0.00157	0.00293	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00157	0.00293	CbGbCtD
Phenobarbital—CYP3A5—Vincristine—hematologic cancer	0.00156	0.00292	CbGbCtD
Phenobarbital—CYP3A4—Bortezomib—hematologic cancer	0.00152	0.00284	CbGbCtD
Phenobarbital—CYP2C19—Prednisone—hematologic cancer	0.00152	0.00284	CbGbCtD
Phenobarbital—CYP2E1—Dexamethasone—hematologic cancer	0.00151	0.00283	CbGbCtD
Phenobarbital—ABCB1—Dasatinib—hematologic cancer	0.00149	0.00279	CbGbCtD
Phenobarbital—CYP2B6—Dexamethasone—hematologic cancer	0.00149	0.00279	CbGbCtD
Phenobarbital—ABCB1—Mitoxantrone—hematologic cancer	0.00147	0.00276	CbGbCtD
Phenobarbital—CYP3A4—Daunorubicin—hematologic cancer	0.00145	0.00272	CbGbCtD
Phenobarbital—CYP3A5—Etoposide—hematologic cancer	0.00143	0.00267	CbGbCtD
Phenobarbital—CYP2C8—Etoposide—hematologic cancer	0.00137	0.00257	CbGbCtD
Phenobarbital—ABCB1—Betamethasone—hematologic cancer	0.00131	0.00246	CbGbCtD
Phenobarbital—ABCB1—Gemcitabine—hematologic cancer	0.0013	0.00244	CbGbCtD
Phenobarbital—ABCB1—Prednisolone—hematologic cancer	0.0013	0.00243	CbGbCtD
Phenobarbital—CYP3A4—Cytarabine—hematologic cancer	0.00128	0.0024	CbGbCtD
Phenobarbital—CYP3A4—Teniposide—hematologic cancer	0.00126	0.00236	CbGbCtD
Phenobarbital—CYP2B6—Doxorubicin—hematologic cancer	0.00124	0.00232	CbGbCtD
Phenobarbital—ABCB1—Prednisone—hematologic cancer	0.00122	0.00229	CbGbCtD
Phenobarbital—CYP3A5—Dexamethasone—hematologic cancer	0.00117	0.0022	CbGbCtD
Phenobarbital—CYP3A4—Ifosfamide—hematologic cancer	0.00117	0.00218	CbGbCtD
Phenobarbital—ABCB1—Irinotecan—hematologic cancer	0.00116	0.00217	CbGbCtD
Phenobarbital—CYP2C8—Dexamethasone—hematologic cancer	0.00113	0.00211	CbGbCtD
Phenobarbital—CYP3A4—Imatinib—hematologic cancer	0.00111	0.00208	CbGbCtD
Phenobarbital—CYP1A2—Etoposide—hematologic cancer	0.00106	0.00199	CbGbCtD
Phenobarbital—CYP3A4—Ruxolitinib—hematologic cancer	0.00105	0.00196	CbGbCtD
Phenobarbital—ABCB1—Vinblastine—hematologic cancer	0.00103	0.00193	CbGbCtD
Phenobarbital—ABCB1—Vincristine—hematologic cancer	0.00101	0.0019	CbGbCtD
Phenobarbital—CYP3A4—Nilotinib—hematologic cancer	0.00101	0.00189	CbGbCtD
Phenobarbital—CYP3A4—Vinorelbine—hematologic cancer	0.001	0.00188	CbGbCtD
Phenobarbital—CYP2C9—Cisplatin—hematologic cancer	0.000975	0.00182	CbGbCtD
Phenobarbital—CYP2C19—Dexamethasone—hematologic cancer	0.000947	0.00177	CbGbCtD
Phenobarbital—ABCB1—Cisplatin—hematologic cancer	0.000946	0.00177	CbGbCtD
Phenobarbital—ABCB1—Etoposide—hematologic cancer	0.00093	0.00174	CbGbCtD
Phenobarbital—CYP3A4—Triamcinolone—hematologic cancer	0.000918	0.00172	CbGbCtD
Phenobarbital—CHRFAM7A—hematopoietic system—hematologic cancer	0.0009	0.0236	CbGeAlD
Phenobarbital—CYP3A4—Dasatinib—hematologic cancer	0.000894	0.00167	CbGbCtD
Phenobarbital—CYP3A4—Mitoxantrone—hematologic cancer	0.000883	0.00165	CbGbCtD
Phenobarbital—CYP4B1—lung—hematologic cancer	0.00086	0.0226	CbGeAlD
Phenobarbital—CYP4B1—testis—hematologic cancer	0.000812	0.0213	CbGeAlD
Phenobarbital—CYP2C9—Dexamethasone—hematologic cancer	0.000788	0.00147	CbGbCtD
Phenobarbital—CYP3A4—Betamethasone—hematologic cancer	0.000787	0.00147	CbGbCtD
Phenobarbital—CYP3A4—Prednisolone—hematologic cancer	0.000777	0.00145	CbGbCtD
Phenobarbital—ABCB1—Dexamethasone—hematologic cancer	0.000764	0.00143	CbGbCtD
Phenobarbital—CYP3A4—Prednisone—hematologic cancer	0.000734	0.00137	CbGbCtD
Phenobarbital—CHRNA7—hematopoietic system—hematologic cancer	0.000727	0.0191	CbGeAlD
Phenobarbital—CHRNA4—hematopoietic system—hematologic cancer	0.000717	0.0188	CbGeAlD
Phenobarbital—CYP3A4—Irinotecan—hematologic cancer	0.000696	0.0013	CbGbCtD
Phenobarbital—ABCC3—hematopoietic system—hematologic cancer	0.000681	0.0178	CbGeAlD
Phenobarbital—ABCB1—Doxorubicin—hematologic cancer	0.000634	0.00119	CbGbCtD
Phenobarbital—CYP3A4—Vinblastine—hematologic cancer	0.000618	0.00116	CbGbCtD
Phenobarbital—ABCB1—Methotrexate—hematologic cancer	0.000614	0.00115	CbGbCtD
Phenobarbital—CYP3A4—Vincristine—hematologic cancer	0.000608	0.00114	CbGbCtD
Phenobarbital—CHRFAM7A—blood—hematologic cancer	0.000596	0.0156	CbGeAlD
Phenobarbital—CYP4B1—lymph node—hematologic cancer	0.000588	0.0154	CbGeAlD
Phenobarbital—ABCB11—testis—hematologic cancer	0.000586	0.0154	CbGeAlD
Phenobarbital—CYP3A4—Etoposide—hematologic cancer	0.000557	0.00104	CbGbCtD
Phenobarbital—GRIA2—testis—hematologic cancer	0.000541	0.0142	CbGeAlD
Phenobarbital—CYP1B1—hematopoietic system—hematologic cancer	0.000533	0.014	CbGeAlD
Phenobarbital—SLCO2A1—lung—hematologic cancer	0.000515	0.0135	CbGeAlD
Phenobarbital—CHRFAM7A—testis—hematologic cancer	0.000493	0.0129	CbGeAlD
Phenobarbital—SLCO2A1—testis—hematologic cancer	0.000486	0.0127	CbGeAlD
Phenobarbital—CHRNA7—blood—hematologic cancer	0.000482	0.0126	CbGeAlD
Phenobarbital—CYP2C19—hematopoietic system—hematologic cancer	0.000467	0.0123	CbGeAlD
Phenobarbital—CYP3A4—Dexamethasone—hematologic cancer	0.000458	0.000857	CbGbCtD
Phenobarbital—ABCC3—blood—hematologic cancer	0.000451	0.0118	CbGeAlD
Phenobarbital—CYP2A6—lung—hematologic cancer	0.000422	0.0111	CbGeAlD
Phenobarbital—CHRNA4—lung—hematologic cancer	0.000417	0.0109	CbGeAlD
Phenobarbital—CYP2C8—hematopoietic system—hematologic cancer	0.000408	0.0107	CbGeAlD
Phenobarbital—CYP1B1—gonad—hematologic cancer	0.000405	0.0106	CbGeAlD
Phenobarbital—CHRNA7—testis—hematologic cancer	0.000398	0.0104	CbGeAlD
Phenobarbital—ABCC3—lung—hematologic cancer	0.000395	0.0104	CbGeAlD
Phenobarbital—CYP1A2—hematopoietic system—hematologic cancer	0.000382	0.01	CbGeAlD
Phenobarbital—CYP3A4—Doxorubicin—hematologic cancer	0.00038	0.000711	CbGbCtD
Phenobarbital—CYP1A1—hematopoietic system—hematologic cancer	0.000376	0.00987	CbGeAlD
Phenobarbital—ABCC3—testis—hematologic cancer	0.000373	0.00978	CbGeAlD
Phenobarbital—CYP3A5—hematopoietic system—hematologic cancer	0.000368	0.00965	CbGeAlD
Phenobarbital—CYP2B6—hematopoietic system—hematologic cancer	0.000366	0.00959	CbGeAlD
Phenobarbital—CYP2C9—hematopoietic system—hematologic cancer	0.000362	0.0095	CbGeAlD
Phenobarbital—ABCC2—blood—hematologic cancer	0.00036	0.00945	CbGeAlD
Phenobarbital—CYP1B1—blood—hematologic cancer	0.000353	0.00925	CbGeAlD
Phenobarbital—SLCO2A1—lymph node—hematologic cancer	0.000352	0.00923	CbGeAlD
Phenobarbital—CYP2E1—hematopoietic system—hematologic cancer	0.000343	0.009	CbGeAlD
Phenobarbital—ABCC1—blood—hematologic cancer	0.000317	0.00832	CbGeAlD
Phenobarbital—CYP2C19—blood—hematologic cancer	0.00031	0.00812	CbGeAlD
Phenobarbital—CYP1B1—lung—hematologic cancer	0.000309	0.00811	CbGeAlD
Phenobarbital—ABCC2—testis—hematologic cancer	0.000298	0.00781	CbGeAlD
Phenobarbital—CYP1B1—testis—hematologic cancer	0.000292	0.00765	CbGeAlD
Phenobarbital—ABCC1—lung—hematologic cancer	0.000278	0.00729	CbGeAlD
Phenobarbital—CYP2B6—gonad—hematologic cancer	0.000278	0.00729	CbGeAlD
Phenobarbital—CYP3A4—hematopoietic system—hematologic cancer	0.000276	0.00724	CbGeAlD
Phenobarbital—ABCC3—lymph node—hematologic cancer	0.00027	0.00709	CbGeAlD
Phenobarbital—CYP2C8—blood—hematologic cancer	0.00027	0.00708	CbGeAlD
Phenobarbital—ABCC1—testis—hematologic cancer	0.000263	0.00688	CbGeAlD
Phenobarbital—CYP1A2—blood—hematologic cancer	0.000253	0.00663	CbGeAlD
Phenobarbital—CYP1A1—blood—hematologic cancer	0.000249	0.00654	CbGeAlD
Phenobarbital—CYP3A5—blood—hematologic cancer	0.000244	0.00639	CbGeAlD
Phenobarbital—CYP2B6—blood—hematologic cancer	0.000242	0.00635	CbGeAlD
Phenobarbital—CYP2C9—blood—hematologic cancer	0.00024	0.00629	CbGeAlD
Phenobarbital—CYP2E1—blood—hematologic cancer	0.000227	0.00596	CbGeAlD
Phenobarbital—CYP2C8—testis—hematologic cancer	0.000224	0.00586	CbGeAlD
Phenobarbital—CYP1A2—lung—hematologic cancer	0.000222	0.00581	CbGeAlD
Phenobarbital—CYP1A1—lung—hematologic cancer	0.000219	0.00573	CbGeAlD
Phenobarbital—ABCC2—lymph node—hematologic cancer	0.000216	0.00566	CbGeAlD
Phenobarbital—CYP3A5—lung—hematologic cancer	0.000214	0.00561	CbGeAlD
Phenobarbital—CYP2B6—lung—hematologic cancer	0.000212	0.00557	CbGeAlD
Phenobarbital—CYP1B1—lymph node—hematologic cancer	0.000212	0.00555	CbGeAlD
Phenobarbital—CYP2B6—testis—hematologic cancer	0.0002	0.00526	CbGeAlD
Phenobarbital—CYP2E1—lung—hematologic cancer	0.000199	0.00523	CbGeAlD
Phenobarbital—ABCB1—hematopoietic system—hematologic cancer	0.000196	0.00513	CbGeAlD
Phenobarbital—ABCC1—lymph node—hematologic cancer	0.00019	0.00499	CbGeAlD
Phenobarbital—CYP2E1—testis—hematologic cancer	0.000188	0.00493	CbGeAlD
Phenobarbital—CYP3A4—blood—hematologic cancer	0.000183	0.0048	CbGeAlD
Phenobarbital—CYP1A1—lymph node—hematologic cancer	0.00015	0.00392	CbGeAlD
Phenobarbital—ABCB1—gonad—hematologic cancer	0.000149	0.0039	CbGeAlD
Phenobarbital—ABCB1—blood—hematologic cancer	0.00013	0.0034	CbGeAlD
Phenobarbital—ABCB1—bone marrow—hematologic cancer	0.000125	0.00329	CbGeAlD
Phenobarbital—ABCB1—lung—hematologic cancer	0.000114	0.00298	CbGeAlD
Phenobarbital—ABCB1—testis—hematologic cancer	0.000107	0.00281	CbGeAlD
Phenobarbital—ABCB1—lymph node—hematologic cancer	7.77e-05	0.00204	CbGeAlD
Phenobarbital—Angioedema—Dexamethasone—hematologic cancer	3.98e-05	0.000313	CcSEcCtD
Phenobarbital—Angioedema—Betamethasone—hematologic cancer	3.98e-05	0.000313	CcSEcCtD
Phenobarbital—Dizziness—Thiotepa—hematologic cancer	3.98e-05	0.000313	CcSEcCtD
Phenobarbital—Rash—Vinorelbine—hematologic cancer	3.97e-05	0.000313	CcSEcCtD
Phenobarbital—Dermatitis—Vinorelbine—hematologic cancer	3.97e-05	0.000312	CcSEcCtD
Phenobarbital—Headache—Vinorelbine—hematologic cancer	3.94e-05	0.000311	CcSEcCtD
Phenobarbital—Asthma—Doxorubicin—hematologic cancer	3.94e-05	0.00031	CcSEcCtD
Phenobarbital—Hypersensitivity—Vincristine—hematologic cancer	3.93e-05	0.000309	CcSEcCtD
Phenobarbital—Vertigo—Dexamethasone—hematologic cancer	3.91e-05	0.000308	CcSEcCtD
Phenobarbital—Vertigo—Betamethasone—hematologic cancer	3.91e-05	0.000308	CcSEcCtD
Phenobarbital—Syncope—Dexamethasone—hematologic cancer	3.91e-05	0.000307	CcSEcCtD
Phenobarbital—Syncope—Betamethasone—hematologic cancer	3.91e-05	0.000307	CcSEcCtD
Phenobarbital—Feeling abnormal—Cisplatin—hematologic cancer	3.89e-05	0.000306	CcSEcCtD
Phenobarbital—Shock—Triamcinolone—hematologic cancer	3.85e-05	0.000303	CcSEcCtD
Phenobarbital—Dizziness—Thalidomide—hematologic cancer	3.85e-05	0.000303	CcSEcCtD
Phenobarbital—Somnolence—Etoposide—hematologic cancer	3.84e-05	0.000302	CcSEcCtD
Phenobarbital—Nausea—Bortezomib—hematologic cancer	3.83e-05	0.000302	CcSEcCtD
Phenobarbital—Loss of consciousness—Dexamethasone—hematologic cancer	3.83e-05	0.000301	CcSEcCtD
Phenobarbital—Loss of consciousness—Betamethasone—hematologic cancer	3.83e-05	0.000301	CcSEcCtD
Phenobarbital—Hypersensitivity—Irinotecan—hematologic cancer	3.83e-05	0.000301	CcSEcCtD
Phenobarbital—Hypersensitivity—Mitoxantrone—hematologic cancer	3.83e-05	0.000301	CcSEcCtD
Phenobarbital—Vomiting—Thiotepa—hematologic cancer	3.82e-05	0.000301	CcSEcCtD
Phenobarbital—Nausea—Bleomycin—hematologic cancer	3.8e-05	0.000299	CcSEcCtD
Phenobarbital—Drowsiness—Epirubicin—hematologic cancer	3.8e-05	0.000299	CcSEcCtD
Phenobarbital—Erythema—Prednisone—hematologic cancer	3.79e-05	0.000299	CcSEcCtD
Phenobarbital—Rash—Thiotepa—hematologic cancer	3.79e-05	0.000298	CcSEcCtD
Phenobarbital—Dermatitis—Thiotepa—hematologic cancer	3.79e-05	0.000298	CcSEcCtD
Phenobarbital—Headache—Thiotepa—hematologic cancer	3.77e-05	0.000297	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	3.76e-05	0.000296	CcSEcCtD
Phenobarbital—Nausea—Vinorelbine—hematologic cancer	3.74e-05	0.000294	CcSEcCtD
Phenobarbital—Renal failure—Epirubicin—hematologic cancer	3.73e-05	0.000294	CcSEcCtD
Phenobarbital—Body temperature increased—Cisplatin—hematologic cancer	3.73e-05	0.000293	CcSEcCtD
Phenobarbital—Myalgia—Dexamethasone—hematologic cancer	3.71e-05	0.000292	CcSEcCtD
Phenobarbital—Myalgia—Betamethasone—hematologic cancer	3.71e-05	0.000292	CcSEcCtD
Phenobarbital—Vomiting—Thalidomide—hematologic cancer	3.7e-05	0.000291	CcSEcCtD
Phenobarbital—Anxiety—Dexamethasone—hematologic cancer	3.7e-05	0.000291	CcSEcCtD
Phenobarbital—Anxiety—Betamethasone—hematologic cancer	3.7e-05	0.000291	CcSEcCtD
Phenobarbital—Dizziness—Carmustine—hematologic cancer	3.69e-05	0.000291	CcSEcCtD
Phenobarbital—Pain—Etoposide—hematologic cancer	3.69e-05	0.000291	CcSEcCtD
Phenobarbital—Constipation—Etoposide—hematologic cancer	3.69e-05	0.000291	CcSEcCtD
Phenobarbital—Rash—Thalidomide—hematologic cancer	3.67e-05	0.000289	CcSEcCtD
Phenobarbital—Dermatitis—Thalidomide—hematologic cancer	3.66e-05	0.000288	CcSEcCtD
Phenobarbital—Dizziness—Alitretinoin—hematologic cancer	3.66e-05	0.000288	CcSEcCtD
Phenobarbital—Headache—Thalidomide—hematologic cancer	3.64e-05	0.000287	CcSEcCtD
Phenobarbital—Pain—Prednisolone—hematologic cancer	3.64e-05	0.000287	CcSEcCtD
Phenobarbital—Hepatitis—Methotrexate—hematologic cancer	3.64e-05	0.000287	CcSEcCtD
Phenobarbital—Dizziness—Ifosfamide—hematologic cancer	3.62e-05	0.000285	CcSEcCtD
Phenobarbital—Nausea—Thiotepa—hematologic cancer	3.57e-05	0.000281	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	3.57e-05	0.000281	CcSEcCtD
Phenobarbital—Feeling abnormal—Etoposide—hematologic cancer	3.56e-05	0.00028	CcSEcCtD
Phenobarbital—Vomiting—Carmustine—hematologic cancer	3.55e-05	0.00028	CcSEcCtD
Phenobarbital—Dizziness—Vincristine—hematologic cancer	3.53e-05	0.000278	CcSEcCtD
Phenobarbital—Rash—Carmustine—hematologic cancer	3.52e-05	0.000277	CcSEcCtD
Phenobarbital—Dermatitis—Carmustine—hematologic cancer	3.52e-05	0.000277	CcSEcCtD
Phenobarbital—Vomiting—Alitretinoin—hematologic cancer	3.52e-05	0.000277	CcSEcCtD
Phenobarbital—Drowsiness—Doxorubicin—hematologic cancer	3.51e-05	0.000277	CcSEcCtD
Phenobarbital—Feeling abnormal—Prednisolone—hematologic cancer	3.51e-05	0.000276	CcSEcCtD
Phenobarbital—Headache—Carmustine—hematologic cancer	3.5e-05	0.000275	CcSEcCtD
Phenobarbital—Shock—Dexamethasone—hematologic cancer	3.5e-05	0.000275	CcSEcCtD
Phenobarbital—Shock—Betamethasone—hematologic cancer	3.5e-05	0.000275	CcSEcCtD
Phenobarbital—Rash—Alitretinoin—hematologic cancer	3.49e-05	0.000275	CcSEcCtD
Phenobarbital—Agitation—Prednisone—hematologic cancer	3.49e-05	0.000274	CcSEcCtD
Phenobarbital—Dermatitis—Alitretinoin—hematologic cancer	3.49e-05	0.000274	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	3.48e-05	0.000274	CcSEcCtD
Phenobarbital—Vomiting—Ifosfamide—hematologic cancer	3.48e-05	0.000274	CcSEcCtD
Phenobarbital—Hypersensitivity—Cisplatin—hematologic cancer	3.47e-05	0.000273	CcSEcCtD
Phenobarbital—Bradycardia—Epirubicin—hematologic cancer	3.47e-05	0.000273	CcSEcCtD
Phenobarbital—Headache—Alitretinoin—hematologic cancer	3.47e-05	0.000273	CcSEcCtD
Phenobarbital—Angioedema—Prednisone—hematologic cancer	3.47e-05	0.000273	CcSEcCtD
Phenobarbital—Nausea—Thalidomide—hematologic cancer	3.46e-05	0.000272	CcSEcCtD
Phenobarbital—Renal failure—Doxorubicin—hematologic cancer	3.45e-05	0.000272	CcSEcCtD
Phenobarbital—Rash—Ifosfamide—hematologic cancer	3.45e-05	0.000271	CcSEcCtD
Phenobarbital—Dermatitis—Ifosfamide—hematologic cancer	3.45e-05	0.000271	CcSEcCtD
Phenobarbital—Erythema multiforme—Methotrexate—hematologic cancer	3.44e-05	0.000271	CcSEcCtD
Phenobarbital—Dizziness—Irinotecan—hematologic cancer	3.43e-05	0.00027	CcSEcCtD
Phenobarbital—Urticaria—Etoposide—hematologic cancer	3.43e-05	0.00027	CcSEcCtD
Phenobarbital—Body temperature increased—Etoposide—hematologic cancer	3.41e-05	0.000269	CcSEcCtD
Phenobarbital—Vertigo—Prednisone—hematologic cancer	3.41e-05	0.000268	CcSEcCtD
Phenobarbital—Hepatitis—Epirubicin—hematologic cancer	3.41e-05	0.000268	CcSEcCtD
Phenobarbital—Syncope—Prednisone—hematologic cancer	3.4e-05	0.000268	CcSEcCtD
Phenobarbital—Vomiting—Vincristine—hematologic cancer	3.39e-05	0.000267	CcSEcCtD
Phenobarbital—Urticaria—Prednisolone—hematologic cancer	3.38e-05	0.000266	CcSEcCtD
Phenobarbital—Rash—Vincristine—hematologic cancer	3.36e-05	0.000265	CcSEcCtD
Phenobarbital—Dermatitis—Vincristine—hematologic cancer	3.36e-05	0.000264	CcSEcCtD
Phenobarbital—Pain—Triamcinolone—hematologic cancer	3.35e-05	0.000264	CcSEcCtD
Phenobarbital—Headache—Vincristine—hematologic cancer	3.34e-05	0.000263	CcSEcCtD
Phenobarbital—Loss of consciousness—Prednisone—hematologic cancer	3.33e-05	0.000262	CcSEcCtD
Phenobarbital—Hypotension—Betamethasone—hematologic cancer	3.32e-05	0.000261	CcSEcCtD
Phenobarbital—Hypotension—Dexamethasone—hematologic cancer	3.32e-05	0.000261	CcSEcCtD
Phenobarbital—Nausea—Carmustine—hematologic cancer	3.32e-05	0.000261	CcSEcCtD
Phenobarbital—Vomiting—Mitoxantrone—hematologic cancer	3.3e-05	0.00026	CcSEcCtD
Phenobarbital—Vomiting—Irinotecan—hematologic cancer	3.3e-05	0.00026	CcSEcCtD
Phenobarbital—Nausea—Alitretinoin—hematologic cancer	3.29e-05	0.000259	CcSEcCtD
Phenobarbital—Rash—Mitoxantrone—hematologic cancer	3.27e-05	0.000258	CcSEcCtD
Phenobarbital—Rash—Irinotecan—hematologic cancer	3.27e-05	0.000258	CcSEcCtD
Phenobarbital—Dermatitis—Irinotecan—hematologic cancer	3.27e-05	0.000258	CcSEcCtD
Phenobarbital—Dermatitis—Mitoxantrone—hematologic cancer	3.27e-05	0.000258	CcSEcCtD
Phenobarbital—Headache—Mitoxantrone—hematologic cancer	3.25e-05	0.000256	CcSEcCtD
Phenobarbital—Headache—Irinotecan—hematologic cancer	3.25e-05	0.000256	CcSEcCtD
Phenobarbital—Nausea—Ifosfamide—hematologic cancer	3.25e-05	0.000256	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.24e-05	0.000255	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.24e-05	0.000255	CcSEcCtD
Phenobarbital—Arthralgia—Prednisone—hematologic cancer	3.23e-05	0.000254	CcSEcCtD
Phenobarbital—Myalgia—Prednisone—hematologic cancer	3.23e-05	0.000254	CcSEcCtD
Phenobarbital—Feeling abnormal—Triamcinolone—hematologic cancer	3.23e-05	0.000254	CcSEcCtD
Phenobarbital—Erythema multiforme—Epirubicin—hematologic cancer	3.22e-05	0.000254	CcSEcCtD
Phenobarbital—Anxiety—Prednisone—hematologic cancer	3.22e-05	0.000253	CcSEcCtD
Phenobarbital—Vomiting—Gemcitabine—hematologic cancer	3.22e-05	0.000253	CcSEcCtD
Phenobarbital—Bradycardia—Doxorubicin—hematologic cancer	3.21e-05	0.000253	CcSEcCtD
Phenobarbital—Rash—Gemcitabine—hematologic cancer	3.19e-05	0.000251	CcSEcCtD
Phenobarbital—Dermatitis—Gemcitabine—hematologic cancer	3.19e-05	0.000251	CcSEcCtD
Phenobarbital—Hypersensitivity—Etoposide—hematologic cancer	3.18e-05	0.000251	CcSEcCtD
Phenobarbital—Erythema—Methotrexate—hematologic cancer	3.17e-05	0.00025	CcSEcCtD
Phenobarbital—Headache—Gemcitabine—hematologic cancer	3.17e-05	0.000249	CcSEcCtD
Phenobarbital—Nausea—Vincristine—hematologic cancer	3.17e-05	0.000249	CcSEcCtD
Phenobarbital—Hepatitis—Doxorubicin—hematologic cancer	3.15e-05	0.000248	CcSEcCtD
Phenobarbital—Hypersensitivity—Prednisolone—hematologic cancer	3.14e-05	0.000247	CcSEcCtD
Phenobarbital—Urticaria—Triamcinolone—hematologic cancer	3.11e-05	0.000245	CcSEcCtD
Phenobarbital—Body temperature increased—Triamcinolone—hematologic cancer	3.1e-05	0.000244	CcSEcCtD
Phenobarbital—Nausea—Irinotecan—hematologic cancer	3.08e-05	0.000243	CcSEcCtD
Phenobarbital—Nausea—Mitoxantrone—hematologic cancer	3.08e-05	0.000243	CcSEcCtD
Phenobarbital—Shock—Prednisone—hematologic cancer	3.05e-05	0.00024	CcSEcCtD
Phenobarbital—Pain—Dexamethasone—hematologic cancer	3.04e-05	0.000239	CcSEcCtD
Phenobarbital—Pain—Betamethasone—hematologic cancer	3.04e-05	0.000239	CcSEcCtD
Phenobarbital—Nausea—Gemcitabine—hematologic cancer	3e-05	0.000237	CcSEcCtD
Phenobarbital—Vomiting—Cisplatin—hematologic cancer	3e-05	0.000236	CcSEcCtD
Phenobarbital—Erythema multiforme—Doxorubicin—hematologic cancer	2.98e-05	0.000235	CcSEcCtD
Phenobarbital—Rash—Cisplatin—hematologic cancer	2.97e-05	0.000234	CcSEcCtD
Phenobarbital—Dermatitis—Cisplatin—hematologic cancer	2.97e-05	0.000234	CcSEcCtD
Phenobarbital—Erythema—Epirubicin—hematologic cancer	2.97e-05	0.000234	CcSEcCtD
Phenobarbital—Feeling abnormal—Betamethasone—hematologic cancer	2.93e-05	0.000231	CcSEcCtD
Phenobarbital—Feeling abnormal—Dexamethasone—hematologic cancer	2.93e-05	0.000231	CcSEcCtD
Phenobarbital—Tension—Epirubicin—hematologic cancer	2.91e-05	0.000229	CcSEcCtD
Phenobarbital—Hypersensitivity—Triamcinolone—hematologic cancer	2.89e-05	0.000227	CcSEcCtD
Phenobarbital—Nervousness—Epirubicin—hematologic cancer	2.88e-05	0.000227	CcSEcCtD
Phenobarbital—Dizziness—Etoposide—hematologic cancer	2.86e-05	0.000225	CcSEcCtD
Phenobarbital—Vertigo—Methotrexate—hematologic cancer	2.85e-05	0.000224	CcSEcCtD
Phenobarbital—Urticaria—Dexamethasone—hematologic cancer	2.82e-05	0.000222	CcSEcCtD
Phenobarbital—Urticaria—Betamethasone—hematologic cancer	2.82e-05	0.000222	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.82e-05	0.000222	CcSEcCtD
Phenobarbital—Dizziness—Prednisolone—hematologic cancer	2.82e-05	0.000222	CcSEcCtD
Phenobarbital—Body temperature increased—Betamethasone—hematologic cancer	2.81e-05	0.000221	CcSEcCtD
Phenobarbital—Body temperature increased—Dexamethasone—hematologic cancer	2.81e-05	0.000221	CcSEcCtD
Phenobarbital—Nausea—Cisplatin—hematologic cancer	2.8e-05	0.00022	CcSEcCtD
Phenobarbital—Vomiting—Etoposide—hematologic cancer	2.75e-05	0.000216	CcSEcCtD
Phenobarbital—Erythema—Doxorubicin—hematologic cancer	2.75e-05	0.000216	CcSEcCtD
Phenobarbital—Agitation—Epirubicin—hematologic cancer	2.73e-05	0.000215	CcSEcCtD
Phenobarbital—Rash—Etoposide—hematologic cancer	2.72e-05	0.000214	CcSEcCtD
Phenobarbital—Dermatitis—Etoposide—hematologic cancer	2.72e-05	0.000214	CcSEcCtD
Phenobarbital—Headache—Etoposide—hematologic cancer	2.71e-05	0.000213	CcSEcCtD
Phenobarbital—Arthralgia—Methotrexate—hematologic cancer	2.7e-05	0.000212	CcSEcCtD
Phenobarbital—Myalgia—Methotrexate—hematologic cancer	2.7e-05	0.000212	CcSEcCtD
Phenobarbital—Tension—Doxorubicin—hematologic cancer	2.69e-05	0.000212	CcSEcCtD
Phenobarbital—Rash—Prednisolone—hematologic cancer	2.69e-05	0.000211	CcSEcCtD
Phenobarbital—Dermatitis—Prednisolone—hematologic cancer	2.68e-05	0.000211	CcSEcCtD
Phenobarbital—Headache—Prednisolone—hematologic cancer	2.67e-05	0.00021	CcSEcCtD
Phenobarbital—Nervousness—Doxorubicin—hematologic cancer	2.67e-05	0.00021	CcSEcCtD
Phenobarbital—Vertigo—Epirubicin—hematologic cancer	2.67e-05	0.00021	CcSEcCtD
Phenobarbital—Syncope—Epirubicin—hematologic cancer	2.66e-05	0.000209	CcSEcCtD
Phenobarbital—Constipation—Prednisone—hematologic cancer	2.65e-05	0.000208	CcSEcCtD
Phenobarbital—Confusional state—Methotrexate—hematologic cancer	2.61e-05	0.000205	CcSEcCtD
Phenobarbital—Loss of consciousness—Epirubicin—hematologic cancer	2.61e-05	0.000205	CcSEcCtD
Phenobarbital—Dizziness—Triamcinolone—hematologic cancer	2.59e-05	0.000204	CcSEcCtD
Phenobarbital—Nausea—Etoposide—hematologic cancer	2.57e-05	0.000202	CcSEcCtD
Phenobarbital—Feeling abnormal—Prednisone—hematologic cancer	2.55e-05	0.000201	CcSEcCtD
Phenobarbital—Nausea—Prednisolone—hematologic cancer	2.53e-05	0.000199	CcSEcCtD
Phenobarbital—Arthralgia—Epirubicin—hematologic cancer	2.53e-05	0.000199	CcSEcCtD
Phenobarbital—Myalgia—Epirubicin—hematologic cancer	2.53e-05	0.000199	CcSEcCtD
Phenobarbital—Agitation—Doxorubicin—hematologic cancer	2.52e-05	0.000199	CcSEcCtD
Phenobarbital—Anxiety—Epirubicin—hematologic cancer	2.52e-05	0.000198	CcSEcCtD
Phenobarbital—Vomiting—Triamcinolone—hematologic cancer	2.49e-05	0.000196	CcSEcCtD
Phenobarbital—Rash—Triamcinolone—hematologic cancer	2.47e-05	0.000194	CcSEcCtD
Phenobarbital—Dermatitis—Triamcinolone—hematologic cancer	2.47e-05	0.000194	CcSEcCtD
Phenobarbital—Vertigo—Doxorubicin—hematologic cancer	2.47e-05	0.000194	CcSEcCtD
Phenobarbital—Syncope—Doxorubicin—hematologic cancer	2.46e-05	0.000194	CcSEcCtD
Phenobarbital—Urticaria—Prednisone—hematologic cancer	2.46e-05	0.000194	CcSEcCtD
Phenobarbital—Headache—Triamcinolone—hematologic cancer	2.45e-05	0.000193	CcSEcCtD
Phenobarbital—Body temperature increased—Prednisone—hematologic cancer	2.45e-05	0.000193	CcSEcCtD
Phenobarbital—Confusional state—Epirubicin—hematologic cancer	2.44e-05	0.000192	CcSEcCtD
Phenobarbital—Hypotension—Methotrexate—hematologic cancer	2.42e-05	0.00019	CcSEcCtD
Phenobarbital—Loss of consciousness—Doxorubicin—hematologic cancer	2.41e-05	0.00019	CcSEcCtD
Phenobarbital—Shock—Epirubicin—hematologic cancer	2.38e-05	0.000188	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.36e-05	0.000186	CcSEcCtD
Phenobarbital—Dizziness—Betamethasone—hematologic cancer	2.35e-05	0.000185	CcSEcCtD
Phenobarbital—Dizziness—Dexamethasone—hematologic cancer	2.35e-05	0.000185	CcSEcCtD
Phenobarbital—Myalgia—Doxorubicin—hematologic cancer	2.34e-05	0.000184	CcSEcCtD
Phenobarbital—Arthralgia—Doxorubicin—hematologic cancer	2.34e-05	0.000184	CcSEcCtD
Phenobarbital—Anxiety—Doxorubicin—hematologic cancer	2.33e-05	0.000183	CcSEcCtD
Phenobarbital—Nausea—Triamcinolone—hematologic cancer	2.33e-05	0.000183	CcSEcCtD
Phenobarbital—Somnolence—Methotrexate—hematologic cancer	2.3e-05	0.000181	CcSEcCtD
Phenobarbital—Hypersensitivity—Prednisone—hematologic cancer	2.28e-05	0.00018	CcSEcCtD
Phenobarbital—Hypotension—Epirubicin—hematologic cancer	2.26e-05	0.000178	CcSEcCtD
Phenobarbital—Vomiting—Dexamethasone—hematologic cancer	2.26e-05	0.000178	CcSEcCtD
Phenobarbital—Vomiting—Betamethasone—hematologic cancer	2.26e-05	0.000178	CcSEcCtD
Phenobarbital—Confusional state—Doxorubicin—hematologic cancer	2.26e-05	0.000178	CcSEcCtD
Phenobarbital—Rash—Dexamethasone—hematologic cancer	2.24e-05	0.000176	CcSEcCtD
Phenobarbital—Rash—Betamethasone—hematologic cancer	2.24e-05	0.000176	CcSEcCtD
Phenobarbital—Dermatitis—Betamethasone—hematologic cancer	2.24e-05	0.000176	CcSEcCtD
Phenobarbital—Dermatitis—Dexamethasone—hematologic cancer	2.24e-05	0.000176	CcSEcCtD
Phenobarbital—Headache—Dexamethasone—hematologic cancer	2.23e-05	0.000175	CcSEcCtD
Phenobarbital—Headache—Betamethasone—hematologic cancer	2.23e-05	0.000175	CcSEcCtD
Phenobarbital—Pain—Methotrexate—hematologic cancer	2.21e-05	0.000174	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.21e-05	0.000174	CcSEcCtD
Phenobarbital—Shock—Doxorubicin—hematologic cancer	2.2e-05	0.000174	CcSEcCtD
Phenobarbital—Somnolence—Epirubicin—hematologic cancer	2.15e-05	0.000169	CcSEcCtD
Phenobarbital—Feeling abnormal—Methotrexate—hematologic cancer	2.13e-05	0.000168	CcSEcCtD
Phenobarbital—Nausea—Dexamethasone—hematologic cancer	2.11e-05	0.000166	CcSEcCtD
Phenobarbital—Nausea—Betamethasone—hematologic cancer	2.11e-05	0.000166	CcSEcCtD
Phenobarbital—Hypotension—Doxorubicin—hematologic cancer	2.09e-05	0.000165	CcSEcCtD
Phenobarbital—Pain—Epirubicin—hematologic cancer	2.07e-05	0.000163	CcSEcCtD
Phenobarbital—Constipation—Epirubicin—hematologic cancer	2.07e-05	0.000163	CcSEcCtD
Phenobarbital—Urticaria—Methotrexate—hematologic cancer	2.06e-05	0.000162	CcSEcCtD
Phenobarbital—Dizziness—Prednisone—hematologic cancer	2.05e-05	0.000161	CcSEcCtD
Phenobarbital—Body temperature increased—Methotrexate—hematologic cancer	2.05e-05	0.000161	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.04e-05	0.000161	CcSEcCtD
Phenobarbital—Feeling abnormal—Epirubicin—hematologic cancer	2e-05	0.000157	CcSEcCtD
Phenobarbital—Somnolence—Doxorubicin—hematologic cancer	1.99e-05	0.000157	CcSEcCtD
Phenobarbital—Vomiting—Prednisone—hematologic cancer	1.97e-05	0.000155	CcSEcCtD
Phenobarbital—Rash—Prednisone—hematologic cancer	1.95e-05	0.000154	CcSEcCtD
Phenobarbital—Dermatitis—Prednisone—hematologic cancer	1.95e-05	0.000154	CcSEcCtD
Phenobarbital—Headache—Prednisone—hematologic cancer	1.94e-05	0.000153	CcSEcCtD
Phenobarbital—Urticaria—Epirubicin—hematologic cancer	1.92e-05	0.000151	CcSEcCtD
Phenobarbital—Pain—Doxorubicin—hematologic cancer	1.92e-05	0.000151	CcSEcCtD
Phenobarbital—Constipation—Doxorubicin—hematologic cancer	1.92e-05	0.000151	CcSEcCtD
Phenobarbital—Body temperature increased—Epirubicin—hematologic cancer	1.91e-05	0.000151	CcSEcCtD
Phenobarbital—Hypersensitivity—Methotrexate—hematologic cancer	1.91e-05	0.00015	CcSEcCtD
Phenobarbital—Feeling abnormal—Doxorubicin—hematologic cancer	1.85e-05	0.000145	CcSEcCtD
Phenobarbital—Nausea—Prednisone—hematologic cancer	1.84e-05	0.000145	CcSEcCtD
Phenobarbital—Hypersensitivity—Epirubicin—hematologic cancer	1.78e-05	0.00014	CcSEcCtD
Phenobarbital—Urticaria—Doxorubicin—hematologic cancer	1.78e-05	0.00014	CcSEcCtD
Phenobarbital—Body temperature increased—Doxorubicin—hematologic cancer	1.77e-05	0.000139	CcSEcCtD
Phenobarbital—Dizziness—Methotrexate—hematologic cancer	1.71e-05	0.000135	CcSEcCtD
Phenobarbital—Hypersensitivity—Doxorubicin—hematologic cancer	1.65e-05	0.00013	CcSEcCtD
Phenobarbital—Vomiting—Methotrexate—hematologic cancer	1.65e-05	0.000129	CcSEcCtD
Phenobarbital—Rash—Methotrexate—hematologic cancer	1.63e-05	0.000128	CcSEcCtD
Phenobarbital—Dermatitis—Methotrexate—hematologic cancer	1.63e-05	0.000128	CcSEcCtD
Phenobarbital—Headache—Methotrexate—hematologic cancer	1.62e-05	0.000128	CcSEcCtD
Phenobarbital—Dizziness—Epirubicin—hematologic cancer	1.6e-05	0.000126	CcSEcCtD
Phenobarbital—Vomiting—Epirubicin—hematologic cancer	1.54e-05	0.000121	CcSEcCtD
Phenobarbital—Nausea—Methotrexate—hematologic cancer	1.54e-05	0.000121	CcSEcCtD
Phenobarbital—Rash—Epirubicin—hematologic cancer	1.53e-05	0.00012	CcSEcCtD
Phenobarbital—Dermatitis—Epirubicin—hematologic cancer	1.53e-05	0.00012	CcSEcCtD
Phenobarbital—Headache—Epirubicin—hematologic cancer	1.52e-05	0.000119	CcSEcCtD
Phenobarbital—Dizziness—Doxorubicin—hematologic cancer	1.48e-05	0.000117	CcSEcCtD
Phenobarbital—Nausea—Epirubicin—hematologic cancer	1.44e-05	0.000113	CcSEcCtD
Phenobarbital—Vomiting—Doxorubicin—hematologic cancer	1.42e-05	0.000112	CcSEcCtD
Phenobarbital—Rash—Doxorubicin—hematologic cancer	1.41e-05	0.000111	CcSEcCtD
Phenobarbital—Dermatitis—Doxorubicin—hematologic cancer	1.41e-05	0.000111	CcSEcCtD
Phenobarbital—Headache—Doxorubicin—hematologic cancer	1.4e-05	0.00011	CcSEcCtD
Phenobarbital—Nausea—Doxorubicin—hematologic cancer	1.33e-05	0.000105	CcSEcCtD
Phenobarbital—ABCB1—Metabolism—NQO1—hematologic cancer	1.89e-06	2.88e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CD44—hematologic cancer	1.89e-06	2.88e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PIK3R1—hematologic cancer	1.88e-06	2.86e-05	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—EP300—hematologic cancer	1.87e-06	2.85e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.87e-06	2.85e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—ENO2—hematologic cancer	1.87e-06	2.85e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—ABCB1—hematologic cancer	1.87e-06	2.84e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.84e-06	2.8e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CYCS—hematologic cancer	1.83e-06	2.79e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—CREBBP—hematologic cancer	1.83e-06	2.78e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—IDH1—hematologic cancer	1.83e-06	2.78e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—EP300—hematologic cancer	1.82e-06	2.77e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	1.82e-06	2.77e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GSTT1—hematologic cancer	1.82e-06	2.76e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PIK3R1—hematologic cancer	1.82e-06	2.76e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—NCOR1—hematologic cancer	1.82e-06	2.76e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—GSTM1—hematologic cancer	1.82e-06	2.76e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—GSTP1—hematologic cancer	1.81e-06	2.76e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PIK3CG—hematologic cancer	1.81e-06	2.75e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.81e-06	2.75e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.81e-06	2.75e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—TXN—hematologic cancer	1.81e-06	2.75e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—CDKN1A—hematologic cancer	1.79e-06	2.73e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CYCS—hematologic cancer	1.79e-06	2.72e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.79e-06	2.72e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—PTEN—hematologic cancer	1.79e-06	2.72e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—HSP90AA1—hematologic cancer	1.78e-06	2.71e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—SDC1—hematologic cancer	1.78e-06	2.7e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.77e-06	2.69e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CD44—hematologic cancer	1.77e-06	2.69e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—NQO1—hematologic cancer	1.77e-06	2.69e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.75e-06	2.67e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—MTHFR—hematologic cancer	1.74e-06	2.64e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PIK3CD—hematologic cancer	1.73e-06	2.64e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PIK3CB—hematologic cancer	1.73e-06	2.64e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.73e-06	2.63e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—ABCB1—hematologic cancer	1.71e-06	2.61e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—ALB—hematologic cancer	1.71e-06	2.61e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—EP300—hematologic cancer	1.71e-06	2.6e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—MTHFR—hematologic cancer	1.7e-06	2.59e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.7e-06	2.59e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—MTHFR—hematologic cancer	1.7e-06	2.58e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.7e-06	2.58e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—CREBBP—hematologic cancer	1.68e-06	2.55e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PIK3CB—hematologic cancer	1.68e-06	2.55e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.67e-06	2.55e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CYCS—hematologic cancer	1.67e-06	2.54e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—NCOR1—hematologic cancer	1.66e-06	2.53e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—GSTM1—hematologic cancer	1.66e-06	2.53e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	1.66e-06	2.53e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—SRC—hematologic cancer	1.66e-06	2.52e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.65e-06	2.52e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.65e-06	2.52e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.64e-06	2.49e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PIK3R1—hematologic cancer	1.64e-06	2.49e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GSTP1—hematologic cancer	1.62e-06	2.46e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.61e-06	2.45e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—MTHFR—hematologic cancer	1.6e-06	2.44e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.6e-06	2.44e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—STAT3—hematologic cancer	1.6e-06	2.43e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—NRAS—hematologic cancer	1.6e-06	2.43e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PIK3CD—hematologic cancer	1.59e-06	2.42e-05	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—PIK3CA—hematologic cancer	1.59e-06	2.41e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GSTP1—hematologic cancer	1.58e-06	2.4e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—ALB—hematologic cancer	1.57e-06	2.39e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.56e-06	2.38e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NUP98—hematologic cancer	1.56e-06	2.38e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—ABCB1—hematologic cancer	1.53e-06	2.33e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—MAPK3—hematologic cancer	1.53e-06	2.33e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.52e-06	2.31e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.52e-06	2.31e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PIK3CB—hematologic cancer	1.51e-06	2.3e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—NQO1—hematologic cancer	1.51e-06	2.3e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CD44—hematologic cancer	1.51e-06	2.3e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NUP214—hematologic cancer	1.5e-06	2.29e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PIK3R1—hematologic cancer	1.5e-06	2.28e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PTEN—hematologic cancer	1.5e-06	2.28e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.5e-06	2.27e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—MYC—hematologic cancer	1.49e-06	2.26e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GSTM1—hematologic cancer	1.49e-06	2.26e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—NCOR1—hematologic cancer	1.49e-06	2.26e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—TGFB1—hematologic cancer	1.48e-06	2.26e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.48e-06	2.25e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.47e-06	2.24e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—MTR—hematologic cancer	1.47e-06	2.24e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GSTP1—hematologic cancer	1.47e-06	2.24e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—MTHFR—hematologic cancer	1.47e-06	2.24e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3CG—hematologic cancer	1.46e-06	2.22e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GSTM1—hematologic cancer	1.45e-06	2.21e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—NCOR1—hematologic cancer	1.45e-06	2.21e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PTEN—hematologic cancer	1.45e-06	2.2e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ENO2—hematologic cancer	1.45e-06	2.2e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3CG—hematologic cancer	1.43e-06	2.18e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—EP300—hematologic cancer	1.43e-06	2.17e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CYCS—hematologic cancer	1.43e-06	2.17e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3CG—hematologic cancer	1.43e-06	2.17e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.43e-06	2.17e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	1.42e-06	2.16e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.41e-06	2.15e-05	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—PIK3CA—hematologic cancer	1.41e-06	2.14e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.4e-06	2.13e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—ABCB1—hematologic cancer	1.4e-06	2.12e-05	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—PIK3CA—hematologic cancer	1.39e-06	2.11e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PIK3CB—hematologic cancer	1.39e-06	2.11e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—EP300—hematologic cancer	1.38e-06	2.1e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—KRAS—hematologic cancer	1.37e-06	2.09e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—SDC1—hematologic cancer	1.37e-06	2.09e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—NCOR1—hematologic cancer	1.35e-06	2.06e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GSTM1—hematologic cancer	1.35e-06	2.06e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—CREBBP—hematologic cancer	1.35e-06	2.06e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—PIK3CA—hematologic cancer	1.35e-06	2.05e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3CG—hematologic cancer	1.35e-06	2.05e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—CREBBP—hematologic cancer	1.33e-06	2.02e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—CREBBP—hematologic cancer	1.32e-06	2.01e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—MTHFR—hematologic cancer	1.31e-06	2e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PTEN—hematologic cancer	1.31e-06	1.99e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.3e-06	1.97e-05	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—AKT1—hematologic cancer	1.3e-06	1.97e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3CD—hematologic cancer	1.28e-06	1.95e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—MTHFR—hematologic cancer	1.28e-06	1.95e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.28e-06	1.94e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—ALB—hematologic cancer	1.27e-06	1.93e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—PIK3CA—hematologic cancer	1.26e-06	1.92e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.26e-06	1.92e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3CD—hematologic cancer	1.26e-06	1.91e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3CD—hematologic cancer	1.25e-06	1.91e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—CREBBP—hematologic cancer	1.25e-06	1.9e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—EP300—hematologic cancer	1.25e-06	1.9e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—ALB—hematologic cancer	1.24e-06	1.89e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—ALB—hematologic cancer	1.24e-06	1.88e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3CG—hematologic cancer	1.24e-06	1.88e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.22e-06	1.85e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3R1—hematologic cancer	1.21e-06	1.84e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PTEN—hematologic cancer	1.2e-06	1.82e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.2e-06	1.82e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.19e-06	1.81e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3R1—hematologic cancer	1.19e-06	1.81e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3CD—hematologic cancer	1.18e-06	1.8e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3R1—hematologic cancer	1.18e-06	1.8e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—ALB—hematologic cancer	1.17e-06	1.78e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—HRAS—hematologic cancer	1.17e-06	1.78e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NQO1—hematologic cancer	1.17e-06	1.77e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CD44—hematologic cancer	1.17e-06	1.77e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.16e-06	1.76e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.16e-06	1.76e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.16e-06	1.76e-05	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—AKT1—hematologic cancer	1.15e-06	1.75e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.15e-06	1.74e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—EP300—hematologic cancer	1.14e-06	1.74e-05	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—AKT1—hematologic cancer	1.13e-06	1.72e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3R1—hematologic cancer	1.12e-06	1.7e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3CB—hematologic cancer	1.12e-06	1.7e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—IL6—hematologic cancer	1.12e-06	1.7e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.1e-06	1.68e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYCS—hematologic cancer	1.1e-06	1.68e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—AKT1—hematologic cancer	1.1e-06	1.68e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.1e-06	1.67e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3CB—hematologic cancer	1.1e-06	1.67e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3CB—hematologic cancer	1.09e-06	1.66e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.09e-06	1.65e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.08e-06	1.64e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—ALB—hematologic cancer	1.07e-06	1.63e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PIK3CA—hematologic cancer	1.06e-06	1.61e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.05e-06	1.6e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3CB—hematologic cancer	1.03e-06	1.57e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—AKT1—hematologic cancer	1.03e-06	1.57e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.03e-06	1.56e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.02e-06	1.56e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.02e-06	1.56e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PIK3CA—hematologic cancer	1.02e-06	1.56e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.01e-06	1.53e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CREBBP—hematologic cancer	9.98e-07	1.52e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTP1—hematologic cancer	9.72e-07	1.48e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3CD—hematologic cancer	9.7e-07	1.48e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PTEN—hematologic cancer	9.66e-07	1.47e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—ALB—hematologic cancer	9.57e-07	1.46e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3CB—hematologic cancer	9.47e-07	1.44e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PTEN—hematologic cancer	9.47e-07	1.44e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3CD—hematologic cancer	9.46e-07	1.44e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PTEN—hematologic cancer	9.45e-07	1.44e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—ALB—hematologic cancer	9.34e-07	1.42e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CREBBP—hematologic cancer	9.32e-07	1.42e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PIK3CA—hematologic cancer	9.22e-07	1.4e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—EP300—hematologic cancer	9.22e-07	1.4e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ABCB1—hematologic cancer	9.2e-07	1.4e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3R1—hematologic cancer	9.16e-07	1.39e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—EP300—hematologic cancer	9.03e-07	1.37e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.01e-07	1.37e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—EP300—hematologic cancer	9.01e-07	1.37e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3R1—hematologic cancer	8.94e-07	1.36e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NCOR1—hematologic cancer	8.93e-07	1.36e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTM1—hematologic cancer	8.93e-07	1.36e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PTEN—hematologic cancer	8.92e-07	1.36e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3CD—hematologic cancer	8.84e-07	1.35e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—ALB—hematologic cancer	8.73e-07	1.33e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—AKT1—hematologic cancer	8.63e-07	1.31e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3CG—hematologic cancer	8.59e-07	1.31e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—EP300—hematologic cancer	8.51e-07	1.29e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3CB—hematologic cancer	8.45e-07	1.29e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PIK3CA—hematologic cancer	8.45e-07	1.29e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—AKT1—hematologic cancer	8.35e-07	1.27e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3R1—hematologic cancer	8.35e-07	1.27e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3CB—hematologic cancer	8.25e-07	1.26e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PTEN—hematologic cancer	8.18e-07	1.24e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CREBBP—hematologic cancer	7.97e-07	1.21e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—MTHFR—hematologic cancer	7.89e-07	1.2e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—EP300—hematologic cancer	7.8e-07	1.19e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3CB—hematologic cancer	7.71e-07	1.17e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3CD—hematologic cancer	7.55e-07	1.15e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—AKT1—hematologic cancer	7.53e-07	1.15e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—ALB—hematologic cancer	7.46e-07	1.13e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PTEN—hematologic cancer	7.3e-07	1.11e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3R1—hematologic cancer	7.13e-07	1.09e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PTEN—hematologic cancer	7.13e-07	1.08e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—EP300—hematologic cancer	6.96e-07	1.06e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—AKT1—hematologic cancer	6.9e-07	1.05e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3CA—hematologic cancer	6.82e-07	1.04e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—EP300—hematologic cancer	6.8e-07	1.03e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3CA—hematologic cancer	6.68e-07	1.02e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3CA—hematologic cancer	6.66e-07	1.01e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PTEN—hematologic cancer	6.66e-07	1.01e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3CG—hematologic cancer	6.63e-07	1.01e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3CB—hematologic cancer	6.58e-07	1e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—EP300—hematologic cancer	6.35e-07	9.66e-06	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3CA—hematologic cancer	6.3e-07	9.58e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CREBBP—hematologic cancer	6.15e-07	9.36e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3CD—hematologic cancer	5.83e-07	8.87e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3CA—hematologic cancer	5.77e-07	8.78e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ALB—hematologic cancer	5.76e-07	8.76e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PTEN—hematologic cancer	5.69e-07	8.66e-06	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—AKT1—hematologic cancer	5.57e-07	8.47e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3R1—hematologic cancer	5.51e-07	8.38e-06	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—AKT1—hematologic cancer	5.45e-07	8.3e-06	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—AKT1—hematologic cancer	5.44e-07	8.28e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—EP300—hematologic cancer	5.43e-07	8.26e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3CA—hematologic cancer	5.15e-07	7.84e-06	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—AKT1—hematologic cancer	5.14e-07	7.83e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3CB—hematologic cancer	5.08e-07	7.73e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3CA—hematologic cancer	5.03e-07	7.65e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—AKT1—hematologic cancer	4.72e-07	7.17e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3CA—hematologic cancer	4.7e-07	7.15e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PTEN—hematologic cancer	4.39e-07	6.68e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—AKT1—hematologic cancer	4.21e-07	6.4e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—EP300—hematologic cancer	4.19e-07	6.37e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—AKT1—hematologic cancer	4.11e-07	6.25e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3CA—hematologic cancer	4.01e-07	6.11e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—AKT1—hematologic cancer	3.84e-07	5.84e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—AKT1—hematologic cancer	3.28e-07	4.99e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3CA—hematologic cancer	3.1e-07	4.71e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—AKT1—hematologic cancer	2.53e-07	3.85e-06	CbGpPWpGaD
